Status:Ongoing

A cross-sectional evaluation of antibody responses to SARS-COV-2 vaccines
Find Out More

Status:Ongoing

Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes and Association with Inflammation and ACEI/ARB Use in a Clinical Setting - Albuminuria Study
Find Out More

Status:Ongoing

Assessing barriers and facilitators to improving prenatal supplementation and preconception fortification in Botswana – a qualitative study
Find Out More

Status:Ongoing

Assessment of proviral reservoir: synergistic combination of reporter cell assay and viral diversity
Find Out More

Status:Ongoing

Birth Outcomes Surveillance Study: Tsepamo Study
Find Out More

Status:Ongoing

Characterization of Anthracycline induced Cardiotoxicity Using Cardiac Magnetic Resonance in Botswana: A Prospective Observational study (Pelo Study)
Find Out More

Status:Ongoing

Contraceptives and Dolutegravir-based ART (CODA) Study
Find Out More

Status:Ongoing

CoVPN 5001: A Prospective Study of Acute Immune Responses to SARS-CoV-2 Infection.
Find Out More

Status:Ongoing

Early Infant Treatment Study: A Clinical Trial of HIV Positive Infants in Botswana
Find Out More

Status:Ongoing

Exploring the Acceptability and Feasibility of COVID19 Testing among Truck Drivers in Botswana
Find Out More

Status:Ongoing

Feasibility and Accuracy of Nanosenor-based cancer diagnosis at the point of care (Chedza Study).
Find Out More

Status:Ongoing

FLOURISH: Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescents who are HIV Exposed Uninfected
Find Out More

Status:Ongoing

HIV and Malignancy in Botswana: An observational Study of Medicine Toxicity of Concurrent Treatment and Clinical Outcomes (Thabatse Study)
Find Out More

Status:Ongoing

HPTN 084: A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
Find Out More

Status:Ongoing

Human Papillomavirus (HPV) Cervical Cancer Screening Study
Find Out More

Status:Ongoing

HVTN 703/HPTN 081 (AMP Study): A phase 2b study to evaluate the efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in Sub- Saharan Africa.
Find Out More

Status:Ongoing

HVTN805/HPTN093: Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who initiated ART in early HIV infection after having received VRC01 or placebo in HVTN 703/HPTN 081.
Find Out More

Status:Ongoing

IMPAACT 2005
Find Out More

Status:Ongoing

IMPAACT 2017 - Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents
Find Out More

Status:Ongoing

IMPAACT 2019 – Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age
Find Out More